Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | 885 hari yang lalu

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | 1040 hari yang lalu

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | 1156 hari yang lalu

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | 1530 hari yang lalu

U.S. Dollar Ticks Lower As Investors Monitor Developments In Middle East

The U.S. Dollar value posted incremental losses on Friday as markets focused on the U.S. call to Iran for discussions to avert a planned intense attack by the U.S. on Iran after November mid-term elections. Iran has not responded until now.

RTTNews | 1 hari yang lalu

TSX Drops Nearly 2.5%; Materials, Tech Stocks Down Sharply

Canadian stocks are down sharply on Friday amid renewed fears about inflation and interest rates following oil prices climbing higher amid supply concerns after a tanker attack in the Strait of Hormuz.

RTTNews | 1 hari yang lalu

Swiss Market Ends Modestly Higher

The Switzerland market's benchmark SMI ended modestly higher on Friday after holding firm throughout the trading session, outperforming most of its peers in Europe.

RTTNews | 1 hari yang lalu

Major European Markets End Mixed As Investors React To Earnings, Economic Data

The major European markets closed mixed on Friday even as most of the other markets across the continent ended notably lower, as investors reacted to a slew of corporate earnings announcements and the latest batch of regional economic data. Higher oil prices and weakness in the tech sector due to renewed uncertainty about returns on AI-related investments hurt sentiment.

RTTNews | 1 hari yang lalu

EURUSD	1.1158	GBPUSD	1.3391
USDJPY	157.546	USDCAD	1.39708